Autoinflammatory Diseases
Özet
Autoinflammatory diseases are described by recurrent attacks of sterile inflammation resulting from disorders in the innate immune system. Pericarditis is the most widespread cardiac involvement of autoinflammatory diseases, some forms may occur with myocarditis. Amyloidosis is one of the most serious complications of autoinflammatory diseases, increasing the risk of cardiac morbidity. Limiting inflammation attacks with treatment also prevents the development of cardiac morbidity. In our article, subtypes of autoinflammatory diseases are described and their cardiac involvements are determined.
Referanslar
Aksentijevich I, Nowak M, Mallah M, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum. 2002 Dec;46(12):3340-8. doi: 10.1002/art.10688. PMID: 12483741; PMCID: PMC4556432.
Zindel J, Kubes P. DAMPs, PAMPs, and LAMPs in Immunity and Sterile Inflammation. Annu Rev Pathol. 2020 Jan 24;15:493-518. doi: 10.1146/annurev-pathmechdis-012419-032847. Epub 2019 Nov 1. PMID: 31675482.
Doria A, Zen M, Bettio S,et al. Autoinflammation and autoimmunity: bridging the divide. Autoimmun Rev. 2012 Nov;12(1):22-30. doi: 10.1016/j.autrev.2012.07.018. Epub 2012 Aug 2. PMID: 22878274.
Marino A, Tirelli F, Giani T, et al. Periodic fever syndromes and autoinflammatory diseases (AIDs). J Transl Autoimmun. 2019 Dec 17;3:100031. doi: 10.1016/j.jtauto.2019.100031. PMID: 32743516; PMCID: PMC7388371.
Pathak S, McDermott MF, Savic S. Autoinflammatory diseases: update on classification diagnosis and management. J Clin Pathol. 2017 Jan;70(1):1-8. doi: 10.1136/jclinpath-2016-203810. Epub 2016 Sep 19. PMID: 27646526.
Nigrovic PA, Lee PY, Hoffman HM. Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach. J Allergy Clin Immunol. 2020 Nov;146(5):925-937. doi: 10.1016/j.jaci.2020.08.017. PMID: 33160483; PMCID: PMC7727443.
Manthiram K, Zhou Q, Aksentijevich I, et al. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation. Nat Immunol. 2017 Jul 19;18(8):832-842. doi: 10.1038/ni.3777. Erratum in: Nat Immunol. 2017 Oct 18;18(11):1271. PMID: 28722725.
Georgin-Lavialle S, Fayand A, Rodrigues F, et al. Autoinflammatory diseases: State of the art. Presse Med. 2019 Feb;48(1 Pt 2):e25-e48. doi: 10.1016/j.lpm.2018.12.003. Epub 2019 Jan 24. PMID: 30686513.
Henderson C, Goldbach-Mansky R. Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis. Curr Opin Rheumatol. 2010 Sep;22(5):567-78. doi: 10.1097/BOR.0b013e32833ceff4. PMID: 20671522; PMCID: PMC3020910.
Migita K, Izumi Y, Jiuchi Y, et al. Familial Mediterranean fever is no longer a rare disease in Japan. Arthritis Res Ther. 2016 Jul 30;18:175. doi: 10.1186/s13075-016-1071-5. PMID: 27473114; PMCID: PMC4967332.
Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell. 1997 Aug 22;90(4):797-807. doi: 10.1016/s0092-8674(00)80539-5. PMID: 9288758.
Chae JJ, Cho YH, Lee GS, et al. Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice. Immunity. 2011 May 27;34(5):755-68. doi: 10.1016/j.immuni.2011.02.020. Epub 2011 May 19. PMID: 21600797; PMCID: PMC3129608.
Xu H, Yang J, Gao W, et al. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature. 2014 Sep 11;513(7517):237-41. doi: 10.1038/nature13449. Epub 2014 Jun 11. PMID: 24919149.
Gershoni-Baruch R, Brik R, Shinawi M, Livneh A. The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet. 2002 Feb;10(2):145-9. doi: 10.1038/sj.ejhg.5200776. PMID: 11938447.
Debeljak M, Toplak N, Abazi N, et al. The carrier rate and spectrum of MEFV gene mutations in central and southeastern European populations. Clin Exp Rheumatol. 2015 Nov-Dec;33(6 Suppl 94):S19-23. Epub 2015 Sep 24. PMID: 26399837.
Ozen S. Update in familial Mediterranean fever. Curr Opin Rheumatol. 2021 Sep 1;33(5):398-402. doi: 10.1097/BOR.0000000000000821. PMID: 34397603.
Sönmez HE, Batu ED, Özen S. Familial Mediterranean fever: current perspectives. J Inflamm Res. 2016 Mar 17;9:13-20. doi: 10.2147/JIR.S91352. PMID: 27051312; PMCID: PMC4803250.
Rigante D, Cantarini L, Imazio M, et al. Autoinflammatory diseases and cardiovascular manifestations. Ann Med. 2011 Aug;43(5):341-6. doi: 10.3109/07853890.2010.547212. Epub 2011 Feb 1. PMID: 21284530.
Berkun Y, Eisenstein EM. Diagnostic criteria of familial Mediterranean fever. Autoimmun Rev. 2014 Apr-May;13(4-5):388-90. doi: 10.1016/j.autrev.2014.01.045. Epub 2014 Jan 11. PMID: 24424166.
Ozdogan H, Ugurlu S. Familial Mediterranean Fever. Presse Med. 2019 Feb;48(1 Pt 2):e61-e76. doi: 10.1016/j.lpm.2018.08.014. Epub 2019 Jan 25. PMID: 30686512
21.Ozen S, Karaaslan Y, Ozdemir O, et al. Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol. 1998 Dec;25(12):2445-9. PMID: 9858443.
Gattorno M, Hofer M, Federici S, et al; Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO). Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis. 2019 Aug;78(8):1025-1032. doi: 10.1136/annrheumdis-2019-215048. Epub 2019 Apr 24. PMID: 31018962.
Kallinich T, Haffner D, Niehues T, et al. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics. 2007 Feb;119(2):e474-83. doi: 10.1542/peds.2006-1434. Epub 2007 Jan 22. PMID: 17242135.
Ozen S, Demirkaya E, Erer B, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016 Apr;75(4):644-51. doi: 10.1136/annrheumdis-2015-208690. Epub 2016 Jan 22. PMID: 26802180.
Kuemmerle-Deschner JB, Gautam R, George AT, et al. Systematic literature review of efficacy/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin D syndrome and tumour necrosis factor receptor-associated periodic syndrome. RMD Open. 2020 Jul;6(2):e001227. doi: 10.1136/rmdopen-2020-001227. PMID: 32723831; PMCID: PMC7722275.
Houten SM, Frenkel J, Waterham HR. Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation. Cell Mol Life Sci. 2003 Jun;60(6):1118-34. doi: 10.1007/s00018-003-2296-4. PMID: 12861380.
Mandey SH, Schneiders MS, Koster J, Waterham HR. Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency. Hum Mutat. 2006 Aug;27(8):796-802. doi: 10.1002/humu.20361. PMID: 16835861.
Munoz MA, Jurczyluk J, Mehr S, et al. Defective protein prenylation is a diagnostic biomarker of mevalonate kinase deficiency. J Allergy Clin Immunol. 2017 Sep;140(3):873-875.e6. doi: 10.1016/j.jaci.2017.02.033. Epub 2017 May 10. PMID: 28501347.
Park YH, Wood G, Kastner DL, Chae JJ. Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol. 2016 Aug;17(8):914-21. doi: 10.1038/ni.3457. Epub 2016 Jun 6. PMID: 27270401; PMCID: PMC4955684.
Durel CA, Aouba A, Bienvenu B, et al. Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood with Mevalonate Kinase Deficiency. Medicine (Baltimore). 2016 Mar;95(11):e3027. doi: 10.1097/MD.0000000000003027. PMID: 26986117; PMCID: PMC4839898.
Ter Haar NM, Oswald M, Jeyaratnam J, et al. Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis. 2015 Sep;74(9):1636-44. doi: 10.1136/annrheumdis-2015-207546. Epub 2015 Jun 24. PMID: 26109736.
Rigante D, Vitale A, Lucherini OM, Cantarini L. The hereditary autoinflammatory disorders uncovered. Autoimmun Rev. 2014 Sep;13(9):892-900. doi: 10.1016/j.autrev.2014.08.001. Epub 2014 Aug 20. PMID: 25149390.
Milhavet F, Cuisset L, Hoffman HM, et al. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat. 2008 Jun;29(6):803-8. doi: 10.1002/humu.20720. PMID: 18409191.
Cantarini L, Lucherini OM, Muscari I, et al. Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives. Autoimmun Rev. 2012 Nov;12(1):38-43. doi: 10.1016/j.autrev.2012.07.020. Epub 2012 Aug 2. PMID: 22884554.
Caso F, Rigante D, Vitale A, et al. Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. Int J Rheumatol. 2013;2013:513782. doi: 10.1155/2013/513782. Epub 2013 Oct 24. PMID: 24282415; PMCID: PMC3824558.
Lane T, Loeffler JM, Rowczenio DM, et al. AA amyloidosis complicating the hereditary periodic fever syndromes. Arthritis Rheum. 2013 Apr;65(4):1116-21. doi: 10.1002/art.37827. PMID: 23280696.
Levy R, Gérard L, Kuemmerle-Deschner J, et al; for PRINTO and Eurofever. Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry. Ann Rheum Dis. 2015 Nov;74(11):2043-9. doi: 10.1136/annrheumdis-2013-204991. Epub 2014 Jul 18. PMID: 25038238.
Barron KS, Kastner DL. Periodic fever syndromes and other inherited autoinflammatory diseases. In: Petty RE, Laxer RM, Lindsay CB, Wedderburn LR, Mellins ED, Fuhlbrigge RC (eds). Textbook of Pediatric Rheumatology (8th ed). Philadelphia: Elsevier, 2021:525-543
Romberg N, Vogel TP, Canna SW. NLRC4 inflammasomopathies. Curr Opin Allergy Clin Immunol. 2017 Dec;17(6):398-404. doi: 10.1097/ACI.0000000000000396. PMID: 28957823; PMCID: PMC6070355.
Grandemange S, Sanchez E, Louis-Plence P, et al. A new autoinflammatory and autoimmune syndrome associated with NLRP1 mutations: NAIAD (NLRP1-associated autoinflammation with arthritis and dyskeratosis). Ann Rheum Dis. 2017 Jul;76(7):1191-1198. doi: 10.1136/annrheumdis-2016-210021. Epub 2016 Dec 13. PMID: 27965258.
Van Nieuwenhove E, De Langhe E, Dooley J, et al. Phenotypic analysis of pyrin-associated autoinflammation with neutrophilic dermatosis patients during treatment. Rheumatology (Oxford). 2021 Nov 3;60(11):5436-5446. doi: 10.1093/rheumatology/keab221. PMID: 33693560.
Genovese G, Moltrasio C, Garcovich S, Marzano AV. PAPA spectrum disorders. G Ital Dermatol Venereol. 2020 Oct;155(5):542-550. doi: 10.23736/S0392-0488.20.06629-8. Epub 2020 Jul 2. PMID: 32618443.
Standing AS, Malinova D, Hong Y, et al. Autoinflammatory periodic fever, immunodeficiency, and thrombocytopenia (PFIT) caused by mutation in actin-regulatory gene WDR1. J Exp Med. 2017 Jan;214(1):59-71. doi: 10.1084/jem.20161228. Epub 2016 Dec 19. PMID: 27994071; PMCID: PMC5206503.
Wu Z, Berlemann LA, Bader V, et al. LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF-κB to the nucleus. EMBO J. 2022 Dec 15;41(24):e112006. doi: 10.15252/embj.2022112006. Epub 2022 Nov 18. PMID: 36398858; PMCID: PMC9753471.
Boisson B, Laplantine E, Prando C, et al. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat Immunol. 2012 Dec;13(12):1178-86. doi: 10.1038/ni.2457. Epub 2012 Oct 28. PMID: 23104095; PMCID: PMC3514453.
Ashour H, Hashem HA, Khowailed AA, et al. Necrostatin-1 mitigates renal ischaemia-reperfusion injury - time dependent - via aborting the interacting protein kinase (RIPK-1)-induced inflammatory immune response. Clin Exp Pharmacol Physiol. 2022 Apr;49(4):501-514. doi: 10.1111/1440-1681.13625. Epub 2022 Feb 10. PMID: 35090059.
Yu MP, Xu XS, et al. Haploinsufficiency of A20 (HA20): updates on the genetics, phenotype, pathogenesis and treatment. World J Pediatr. 2020 Dec;16(6):575-584. doi: 10.1007/s12519-019-00288-6. Epub 2019 Oct 5. PMID: 31587140.
Damgaard RB, Jolin HE, Allison MED, et al. OTULIN protects the liver against cell death, inflammation, fibrosis, and cancer. Cell Death Differ. 2020 May;27(5):1457-1474. doi: 10.1038/s41418-020-0532-1. Epub 2020 Mar 30. PMID: 32231246; PMCID: PMC7206033.
Matsuda T, Kambe N, Takimoto-Ito R, et al. Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis. Front Immunol. 2022 May 27;13:895765. doi: 10.3389/fimmu.2022.895765. PMID: 35711422; PMCID: PMC9195515.
Cetin Gedik K, Lamot L, Romano M, et al. The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS. Ann Rheum Dis. 2022 May;81(5):601-613. doi: 10.1136/annrheumdis-2021-221814. Epub 2022 Jan 27. PMID: 35086813; PMCID: PMC9036471.
Meyts I, Aksentijevich I. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment. J Clin Immunol. 2018 Jul;38(5):569-578. doi: 10.1007/s10875-018-0525-8. Epub 2018 Jun 27. PMID: 29951947; PMCID: PMC6061100.
Adler Y, Charron P, Imazio M, et al ; ESC Scientific Document Group. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015 Nov 7;36(42):2921-2964. doi: 10.1093/eurheartj/ehv318. Epub 2015 Aug 29. PMID: 26320112; PMCID: PMC7539677.
Romano M, Arici ZS, Piskin D, et al. The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist. Ann Rheum Dis. 2022 Jul;81(7):907-921. doi: 10.1136/annrheumdis-2021-221801. Epub 2022 May 27. PMID: 35623638.
Hospach T, Glowatzki F, Blankenburg F, et al. Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents. Pediatr Rheumatol Online J. 2019 Jul 8;17(1):37. doi: 10.1186/s12969-019-0338-1. PMID: 31286990; PMCID: PMC6615208.
